HLA-Cw*0602 associates with a twofold higher prevalence of positive streptococcal throat swab at the onset of psoriasis: a case control study
- PMID: 19480679
- PMCID: PMC2696405
- DOI: 10.1186/1471-5945-9-5
HLA-Cw*0602 associates with a twofold higher prevalence of positive streptococcal throat swab at the onset of psoriasis: a case control study
Abstract
Background: The influence of streptococcal infections in the pathogenesis of psoriasis is not yet understood. In vitro data suggest that streptococcal factors influence T-cell function in psoriasis in a HLA-dependent manner, but studies designed to measure the HLA-C/Streptococci interaction are lacking. In the present study, we hypothesized that there is a statistical interaction between the result of streptococcal throat cultures and the presence of the HLA-Cw*0602 allele in psoriasis patients.
Methods: We performed a case control study using the "Stockholm Psoriasis Cohort" consisting of patients consecutively recruited within 12 months of disease onset (Plaque psoriasis = 439, Guttate psoriasis = 143), matched to healthy controls (n = 454) randomly chosen from the Swedish Population Registry. All individuals underwent physical examination including throat swabs and DNA isolation for HLA-Cw*0602 genotyping. The prevalence of positive streptococcal throat swabs and HLA-Cw*0602 was compared between patients and controls and expressed as odds ratios with 95% confidence intervals. Associations were evaluated separately for guttate and plaque psoriasis by Fisher's exact test.
Results: Regardless of disease phenotype, the prevalence of positive streptococcal throat swabs in HLA-Cw*0602 positive patients was twice the prevalence among HLA-Cw*0602 negative patients (OR = 5.8 C.I. = 3.57-9.67, p < 0.001), while no difference was observed among Cw*0602 positive versus negative controls. The corresponding odds ratios for the guttate and plaque psoriasis phenotypes were 3.5 (CI = 1.5-8.7, p = 0.01) and 2.3 (CI = 1.0-5.1, p = 0.02) respectively.
Conclusion: These findings suggest that among HLA-Cw*0602 positive psoriasis patients, streptococci may contribute to the onset or exacerbation of the inflammatory process independent of the disease phenotype. However, studies on the functional interaction between HLA-C and streptococcal factors are needed.
Similar articles
-
HLA-Cw6 homozygosity in plaque psoriasis is associated with streptococcal throat infections and pronounced improvement after tonsillectomy: A prospective case series.J Am Acad Dermatol. 2016 Nov;75(5):889-896. doi: 10.1016/j.jaad.2016.06.061. Epub 2016 Aug 9. J Am Acad Dermatol. 2016. PMID: 27520394 Free PMC article.
-
HLA Cw*06 is not essential for streptococcal-induced psoriasis.Br J Dermatol. 2006 May;154(5):850-3. doi: 10.1111/j.1365-2133.2005.07101.x. Br J Dermatol. 2006. PMID: 16634885
-
HLA-C and guttate psoriasis.Br J Dermatol. 2000 Dec;143(6):1177-82. doi: 10.1046/j.1365-2133.2000.03885.x. Br J Dermatol. 2000. PMID: 11122018
-
HLA-Cw6 and psoriasis.Br J Dermatol. 2018 Apr;178(4):854-862. doi: 10.1111/bjd.16083. Epub 2018 Mar 2. Br J Dermatol. 2018. PMID: 29072309 Review.
-
HLA-Cw1 and Psoriasis.Am J Clin Dermatol. 2021 May;22(3):339-347. doi: 10.1007/s40257-020-00585-1. Epub 2021 Jan 18. Am J Clin Dermatol. 2021. PMID: 33460021 Free PMC article. Review.
Cited by
-
Triggers for the onset and recurrence of psoriasis: a review and update.Cell Commun Signal. 2024 Feb 12;22(1):108. doi: 10.1186/s12964-023-01381-0. Cell Commun Signal. 2024. PMID: 38347543 Free PMC article. Review.
-
The Psoriasis Risk Allele HLA-C*06:02 Shows Evidence of Association with Chronic or Recurrent Streptococcal Tonsillitis.Infect Immun. 2018 Sep 21;86(10):e00304-18. doi: 10.1128/IAI.00304-18. Print 2018 Oct. Infect Immun. 2018. PMID: 30037793 Free PMC article.
-
HLA-Cw6 homozygosity in plaque psoriasis is associated with streptococcal throat infections and pronounced improvement after tonsillectomy: A prospective case series.J Am Acad Dermatol. 2016 Nov;75(5):889-896. doi: 10.1016/j.jaad.2016.06.061. Epub 2016 Aug 9. J Am Acad Dermatol. 2016. PMID: 27520394 Free PMC article.
-
Childhood guttate psoriasis: an updated review.Drugs Context. 2023 Oct 23;12:2023-8-2. doi: 10.7573/dic.2023-8-2. eCollection 2023. Drugs Context. 2023. PMID: 37908643 Free PMC article. Review.
-
Systemic Psoriasis: From Molecular Mechanisms to Global Management Strategies.Clin Rev Allergy Immunol. 2025 Aug 7;68(1):79. doi: 10.1007/s12016-025-09089-4. Clin Rev Allergy Immunol. 2025. PMID: 40775488 Review.
References
-
- Parks CG, Cooper GS, Hudson LL, Dooley MA, Treadwell EL, St Clair EW, Gilkeson GS, Pandey JP. Association of Epstein-Barr virus with systemic lupus erythematosus: effect modification by race, age, and cytotoxic T lymphocyte-associated antigen 4 genotype. Arthritis Rheum. 2005;52:1148–1159. doi: 10.1002/art.20997. - DOI - PubMed
-
- Fraser PA, Ding WZ, Mohseni M, Treadwell EL, Dooley MA, St Clair EW, Gilkeson GS, Cooper GS. Glutathione S-transferase M null homozygosity and risk of systemic lupus erythematosus associated with sun exposure: a possible gene-environment interaction for autoimmunity. J Rheumatol. 2003;30:276–282. - PubMed
-
- Arnetz BB, Fjellner B, Eneroth P, Kallner A. Stress and psoriasis: psychoendocrine and metabolic reactions in psoriatic patients during standardized stressor exposure. Psychosom Med. 1985;47:528–541. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials